Fibriant

About:

We are a young biotech company located in the Bioscience Park in Leiden.

Top Investors: European Innovation Council, UNIIQ

Description:

is a biotech startup focusing on the development and production of recombinant fibrinogen. Fibrinogen is a protein found in blood and plays an important role in blood clotting, tissue repair and natural defences against infections.

Total Funding Amount:

16.8M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Leiden, Zuid-Holland, The Netherlands

Founded Date:

2015-01-01

Contact Email:

info(AT)fibriant.com

Founders:

Jaap Koopman, Jos Grimbergen

Number of Employees:

1-10

Last Funding Date:

2021-10-06

IPO Status:

Private

Industries: